Key statistics
As of last trade Pharvaris NV (PHVS:NSQ) traded at 27.07, -9.15% below its 52-week high of 29.80, set on Dec 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 27.44 |
|---|---|
| High | 27.44 |
| Low | 26.99 |
| Bid | 26.27 |
| Offer | 27.98 |
| Previous close | 27.48 |
| Average volume | 142.28k |
|---|---|
| Shares outstanding | 64.06m |
| Free float | 42.30m |
| P/E (TTM) | -- |
| Market cap | 1.76bn USD |
| EPS (TTM) | -3.47 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 14:41 GMT.
More ▼
- Pharvaris to Present Clinical Data at the AAAAI 2026 Annual Meeting
- Pharvaris Outlines 2026 Strategic Priorities
- Pharvaris Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks
- Pharvaris Reports Third Quarter 2025 Financial Results and Provides Business Update
- Data Supporting the Potentially Differentiated Pharvaris Portfolio Presented at ACAAI 2025 Annual Scientific Meeting
- Pharvaris to Present Clinical Data at the ACAAI 2025 Annual Scientific Meeting
- Pharvaris Reports Second Quarter 2025 Financial Results and Provides Business Update
- Pharvaris Announces Closing of $201.2 Million Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
- Pharvaris Announces Proposed Public Offering of Ordinary Shares
More ▼
